Select Page

Dr. Lorrie Kirshenbaum

Director
Institute of Cardiovascular Sciences

Principal Investigator
Cardiac Gene Biology, Institute of Cardiovascular Sciences

Professor
Department of Physiology, University of Manitoba

Canada Research Chair
Molecular Cardiology, University of Manitoba

Director of Research Development
Faculty of Medicine, University of Manitoba

Institute of Cardiovascular Sciences

Widely regarded as one of the preeminent basic cardiovascular research programs in the world, St. Boniface’s Institute of Cardiovascular Sciences, led by Dr. Lorrie Kirshenbaum, is a leading force in the fight against heart disease at the cellular and molecular levels.

Research Manitoba Awards announced

Niketa Sareen and Glen Lester Sequiera Congratulations to the following students/postdocs from the Dhingra Lab (Cardiac Regeneration and Tissue Engineering Laboratory, Institute of Cardiovascular Sciences ) who were successful in receiving Research Manitoba Fellowship...

Ivan Berkowitz MBA

The Institute of Cardiovascular Sciences’ good friend and colleague, Ivan Berkowitz, passed away on Thursday, June 15, 2017. In his capacity as Editor of CV Network and Heart Health Scholar of the Academy for more than 15 years, Ivan played a critical role in the...

Kirshenbaum appointed Director, Institute of Cardiovascular Sciences

The University of Manitoba and St. Boniface Hospital announce the appointment of Dr. Lorrie Kirshenbaum as Director of the Institute of Cardiovascular Sciences (ICS) at the Albrechtsen Research Centre at St. Boniface Hospital. Dr. Kirshenbaum assumes this role...

Czubryt patent highlighted in “Believe”

The research of Dr. Michael Czubryt , Principal Investigator, Molecular Pathophysiology, Institute of Cardiovascular Sciences, is highlighted in the Spring 2017 issue of Believe, produced by the St. Boniface Hospital Foundation. Dr. Czubryt has patented a way to...

New weapon in fight against antibiotic resistance discovered

Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 “priority pathogens” recently defined by the World Health Organization (WHO) as antiobiotic-resistant bacteria requiring...

Foundation highlights blackberries/blueberries research

The St. Boniface Hospital Foundation recently put the spotlight on the research of Dr. Jeffrey Wigle (Vascular Development, Institute of Cardiovascular Sciences) and Dr. Thomas Netticadan (Heart Failure Research Laboratory, Canadian Centre for Agri-food Research in...